Will These Stocks Grow? Alexion Pharmaceuticals (ALXN), Charles River Laboratories Intl. Inc (CRL)

0
30

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Stock’s Trading Stats:

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) surged 0.58% yesterday and closed at $148.89. The company’s market capitalization is at $33.65 Billion with an average trading volume of 1.78 Million. The total number of Outstanding Shares Held by the company are 224.74 Million.

Recent Press Release:

Alexion Pharmaceuticals, Inc. (ALXN) on April 4, 2016 declared that researchers presented new data showing children with perinatal- and infantile-onset hypophosphatasia (HPP) treated with Strensiq® (asfotase alfa) had statistically noteworthy improvements in bone healing as assessed radiographically, which were sustained through 3.5 years of treatment.1 The data were from an ongoing, open-label Phase 2 trial of Strensiq, which formerly demonstrated a 90 percent overall observed survival rate and improvements in respiratory status that continue to be sustained. The data were presented at the Endocrine Society’s 98th Annual Meeting and Expo (ENDO) in Boston.

Researchers also presented the following data:

  • Clinically noteworthy improvements in physical function were observed in children with HPP (ages 11-17 years at analysis) who were treated with Strensiq for up to 5 years (n=12).2
  • New interim results indicating a reduction in two key tissue non-specific alkaline phosphatase (TNSALP) substrates that accumulate in HPP, in addition to improvements in physical function in adolescent and adult patients with HPP (ages 13-66 years at study entry) treated with Strensiq, as measured by:3
  • 6 Minute Walk Test (6MWT) (n=19).
  • Reduction or elimination of ambulatory assistive devices during performance of the 6MWT by 2 years of treatment for all patients that required them at baseline (n=5).

Charles River Laboratories Intl. Inc (NYSE:CRL)

Stock’s Trading Stats:

Charles River Laboratories Intl. Inc (NYSE:CRL) closed at $81.90 yesterday by showing a increase of 0.55%. The total number of outstanding shares held by the company are 47.10 Million with the total market capitalization of $3.88 billion. The number of shares traded on the last trading session are 801,600.

Recent Press Release:

Charles River Laboratories Intl. Inc (CRL) declared on April 7, 2016 it will release first-quarter 2016 financial results on Wednesday, May 4th before the market opens. A conference call has been planned to discuss this information on Wednesday, May 4th, at 8:30 a.m. ET.

Shareholders will have the opportunity to listen to a live webcast of the conference call through the Shareholder Relations section of the Company’s website at ir.criver.com. A replay will be accessible through the same website.